Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 16
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04469920 | Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function | ||
| NCT03863574 | Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis | ||
| NCT05045482 | Hepatic Impairment with Cirrhosis Due to Cholestatic Liver Disease | ||
| NCT03617263 | Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII) | ||
| NCT04045769 | A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers | ||
| NCT03112681 | Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis | ||
| NCT04112446 | Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects | ||
| NCT03639623 | Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD) | ||
| NCT05133336 | Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis | ||
| NCT05211284 | Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US | ||
| NCT03061721 | Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis | ||
| NCT06427395 | Open-Label Extension Study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis | ||
| NCT06825559 | Evaluating Pharmacokinetic and Safety of Saroglitazar Magnesium 1 Mg When Dosed on Alternate Days in Subjects Having Moderate Hepatic Impairment with Cirrhosis Due to Cholestatic Liver Disease | ||
| NCT04446507 | A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal Function | ||
| NCT03097107 | Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL | ||
| NCT05011305 | Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis |
